Overall occurrence of BRCA mutations in biliary tract cancers has been reported as 3.6% with a BRCA2 predominance (0.6% have a BRCA1 mutation and 3% have a BRCA2 mutation) [10]. The gene discussed is BRCA2; the disease is biliary tract neoplasm.